1-Tert-butyl-3-(4-fluoro-3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine | 956025-73-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1-Tert-butyl-3-(4-fluoro-3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine
• CAS: 956025-73-3
• 化学式: C₁₆H₁₈FN₅
• 分子量: 299.351
• InChiKey: AOXRSVUHNJJKDP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  69.6
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• PYRAZOLO PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF
  申请人：The Regents of the University of California

  公开号：US20160168151A1

  公开（公告）日：2016-06-16

  This invention generally relates to pyrazolo pyrimidine derivatives useful as, inter alia, inhibitors of short chain dehydrogenase/reductase (SDR) family of NAD(P)(H) dependent oxido-reductases. More specifically, the invention relates to pyrazolo pyrimidine derivatives, including derivatives and analogs of SDR inhibitors, pharmaceutical compositions containing derivatives and analogs of SDR inhibitors, methods of making derivatives and analogs of SDR inhibitors and methods of use thereof.

  本发明通常涉及作为短链脱氢酶/还原酶（SDR）家族NAD（P）（H）依赖性氧化还原酶的抑制剂的吡唑嘧啶衍生物。更具体地，本发明涉及吡唑嘧啶衍生物，包括SDR抑制剂的衍生物和类似物，含有SDR抑制剂的衍生物和类似物的制药组合物，制备SDR抑制剂的衍生物和类似物的方法以及其使用方法。
• Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof
  申请人：Tanaka Masahiro

  公开号：US20120065154A1

  公开（公告）日：2012-03-15

  This invention generally relates to pyrazolo pyrimidine derivatives useful as, inter alia, inhibitors of short chain dehydrogenase/reductase (SDR) family of NAD(P)(H) dependent oxido-reductases. More specifically, the invention relates to pyrazolo pyrimidine derivatives, including derivatives and analogs of SDR inhibitors, pharmaceutical compositions containing derivatives and analogs of SDR inhibitors, methods of making derivatives and analogs of SDR inhibitors and methods of use thereof.

  本发明通常涉及吡唑并嘧啶衍生物，可用作短链脱氢酶/还原酶（SDR）家族的NAD（P）（H）依赖性氧化还原酶的抑制剂等。更具体地，本发明涉及吡唑并嘧啶衍生物，包括SDR抑制剂的衍生物和类似物，含有SDR抑制剂的衍生物和类似物的制药组合物，制备SDR抑制剂的衍生物和类似物的方法以及使用它们的方法。
• INHIBITION OF ALPHA-SYNUCLEIN TOXICITY
  申请人：Lindquist Susan L.

  公开号：US20100273776A1

  公开（公告）日：2010-10-28

  Compounds and compositions are provided for treatment or amelioration of one or more symptoms of α-synuclein toxicity, α-synuclein mediated diseases or diseases in which α-synuclein fibrils are a symptom or cause of the disease.

  提供了用于治疗或缓解α-突触核蛋白毒性、α-突触核蛋白介导的疾病或α-突触核蛋白纤维是疾病的症状或原因之一的化合物和组合物。
• MODULATION OF PROTEIN TRAFFICKING
  申请人：Bulawa Christine Ellen

  公开号：US20100331297A1

  公开（公告）日：2010-12-30

  Compounds and compositions are provided for treatment or amelioration of one or more disorders characterized by defects in protein trafficking. A method of treating a disorder characterized by impaired protein trafficking includes administering to a subject or contacting a cell with a compound of Formula I: [formula here] or pharmaceutically acceptable salts or derivatives thereof.

  本发明提供用于治疗或改善由蛋白质运输缺陷所特征的一个或多个疾病的化合物和组合物。一种治疗由蛋白质运输受损所特征的疾病的方法包括向受试者施用或与细胞接触化合物I的药物或其药学上可接受的盐或衍生物。[公式在此]